The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in ...

MRSA is an antimicrobial resistance (AMR) superbug that causes over 120,000 deaths per year. Given the urgent need for new, more effective antibiotics and a lack of MRSA vaccines, understanding ...

As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive ...

A mom has said her 11-day-old daughter died from an infection at an 'absolutely putrid' hospital at an inquiry into the ...

MRSA - or methicillin resistant staphylococcus aureus - has already become resistant to most common antibiotics, making it difficult to treat with drugs. Once it gets into the body, through wounds ...

A newly developed laboratory tool can, within hours, help to identify specific viruses which can be used to destroy variants ...

Basilea opts not to take MRSA antibiotic into clinic due to 'stringent risk-return criteria' “The powerful synthetic methods we've developed at the Myers Lab have enabled us to create a series ...

Resistance development of MRSA has become a global health problem. New resistance types, such as vancomycin-resistant S. aureus, have been recently developed. Novel antibiotics, such as linezolid ...